Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis
- PMID: 33616741
- DOI: 10.1007/s00415-021-10473-1
Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis
Abstract
Background: Helicobacter pylori (HP) infection has been reported to be associated with increased severity of Parkinson's disease (PD) and have negative effects on drug response in patients. We aimed to investigate the influence of HP infection on patients with PD using a systematic review and meta-analysis approach.
Methods: PubMed and EMBASE databases for relevant articles published before October 2020 were searched. Two authors independently screened records, extracted data, and evaluated the quality of the included studies. The odds ratios (ORs) or standardized mean differences (SMDs) with their corresponding 95% confidence intervals (CIs) were used to calculate the pooled results by employing a random or fixed-effects model. Sensitivity analyses were conducted, and potential publication bias was assessed.
Results: A total of 13 studies were included in our meta-analysis. Overall, PD patients with HP infection had significantly higher levodopa equivalent daily dose (UPDRS) motor scores (SMD = 0.266; 95% CI 0.065-0.467; P = 0.009) and more units of levodopa equivalent daily dose (LEDD) (SMD = 0.178; 95% CI 0.004-0.353; P = 0.046) than those of patients without HP infection. Additionally, the time to achieve 'ON' state was significantly longer (SMD = 0.778; 95% CI 0.337-1.220; P = 0.001) and the duration of 'ON' state was significantly shorter (SMD = -0.539; 95% CI = -0.801 to -0.227; P = 0.001) in patients with HP infection than in those without HP infection.
Conclusion: Our pooled results of this meta-analysis demonstrated that HP infection was associated with worse motor symptoms, higher LEDD, and worse response to drugs in patients with PD. This evidence emphasizes the importance of considering subsequent eradication of HP infection in patients with PD.
Keywords: Helicobacter pylori; Levodopa equivalent daily dose; Motor symptoms; Parkinson's disease; Response to levodopa.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.
Similar articles
-
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20. Adv Ther. 2021. PMID: 34018146 Free PMC article.
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2. Cochrane Database Syst Rev. 2021. PMID: 35608903 Free PMC article.
-
Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson's disease: a systematic review and meta-analysis.J Neurol. 2025 Feb 1;272(2):176. doi: 10.1007/s00415-025-12894-8. J Neurol. 2025. PMID: 39891751
-
Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis.Chin Med J (Engl). 2018 Nov 20;131(22):2734-2740. doi: 10.4103/0366-6999.245269. Chin Med J (Engl). 2018. PMID: 30425200 Free PMC article.
Cited by
-
Helicobacter pylori infection and Parkinson's Disease: etiology, pathogenesis and levodopa bioavailability.Immun Ageing. 2024 Jan 2;21(1):1. doi: 10.1186/s12979-023-00404-1. Immun Ageing. 2024. PMID: 38166953 Free PMC article. Review.
-
Could the Urease of the Gut Bacterium Proteus mirabilis Play a Role in the Altered Gut-Brain Talk Associated with Parkinson's Disease?Microorganisms. 2023 Aug 9;11(8):2042. doi: 10.3390/microorganisms11082042. Microorganisms. 2023. PMID: 37630602 Free PMC article.
-
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease.Gut Microbes. 2025 Dec;17(1):2454937. doi: 10.1080/19490976.2025.2454937. Epub 2025 Jan 28. Gut Microbes. 2025. PMID: 39875349 Free PMC article. Review.
-
The gastrointestinal tract and Parkinson's disease.Front Cell Infect Microbiol. 2024 Jan 15;13:1158986. doi: 10.3389/fcimb.2023.1158986. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38292855 Free PMC article. Review. No abstract available.
-
Association between microbiological risk factors and neurodegenerative disorders: An umbrella review of systematic reviews and meta-analyses.Front Psychiatry. 2022 Sep 23;13:991085. doi: 10.3389/fpsyt.2022.991085. eCollection 2022. Front Psychiatry. 2022. PMID: 36213914 Free PMC article.
References
-
- Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912 - DOI
-
- Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K et al (2018) Validation of the MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 33(10):1601–1608 - DOI
-
- Tysnes OB, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 124(8):901–905 - DOI
-
- Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15(12):1257–1272 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous